Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Tat-CBD3A6K is a peptide and derivative of the N-type voltage-gated calcium channel Cav2.2 and collapsin response mediator protein 2 (CRMP2) protein-protein interaction inhibitor Tat-CBD3 (Item No. 37448).1,2 Tat-CBD3A6K (10 mg/kg) prevents decreases in the paw withdrawal threshold in a rat model of antiretroviral neuropathic pain induced by d4T (stavudine; Item No. 14975) and decreases the number of action potentials from dorsal root ganglia (DRG) neurons isolated from the same rats.1 Dural administration of Tat-CBD3A6K decreases meningeal blood flow induced by the terpene alkaloid capsaicin (Item Nos. 92350 | 10010743) in rats.2
WARNING This product is not for human or veterinary use.
1. CRMP-
2. Further insights into the antinociceptive potential of a peptide disrupting the N-